ImmunoConcEpT - UMR 5164: envíos recientes
Mostrando ítems 21-40 de 375
-
Characterization of the novel HLA-B*51:394Q allele by sequencing-based typing
(HLA. vol. 103, n° 2, 2024-02)Article de revue -
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks
(Journal of the European Academy of Dermatology and Venereology, 2024-07)Article de revueLibre acceso -
The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients over the First Year Posttransplantation
(Transplantation Direct. vol. 10, n° 8, pp. e1678, 2024-08)Article de revueLibre acceso -
Characterisation of the novel HLA-A*26:247 allele by sequencing-based typing
(HLA. vol. 104, n° 3, 2024-09)Article de revue -
Characterisation of the novel HLA-DQA1*01:02:24 allele by sequencing-based typing
(HLA. vol. 104, n° 3, 2024-09)Article de revue -
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes
(Journal of the European Academy of Dermatology and Venereology. vol. 38, n° 7, pp. 1251 – 1280)Article de revue -
Methodological advice for the young at heart investigator: Triangulation to build better foundations
(Brain, Behavior, and Immunity. vol. 115, pp. 737 – 746, 2024-01)Article de revueLibre acceso -
Ultra-overt therapy: a novel medical approach centered on patient consciousness
(Frontiers in Integrative Neuroscience. vol. 18, 2024-08)Article de revueLibre acceso -
Inflated expectations: the strange craze for translational research on aging: Given existing confusion about the basic science of aging, why the high optimism in the private sector about the prospects of developing anti-aging treatments?
(EMBO Reports. vol. 25, n° 9, pp. 3748 – 3752, 2024-08)Article de revueLibre acceso -
Influence of Splenomegaly and Splenectomy on the Immune Cell Profile of Patients with Common Variable Immunodeficiency Disease
(Journal of clinical immunology. vol. 44, n° 2, 2024-01)Article de revue -
Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration
(Journal of Clinical Investigation. vol. 134, n° 11, 2024-04)Article de revueLibre acceso -
Characterisation of the novel HLA-DRB1*08:126 allele by sequencing-based typing
(HLA. vol. 104, n° 2, 2024-08)Article de revue -
The Microscope and Beyond: Current Trends in the Characterization of Kidney Allograft Rejection From Tissue Samples
(Transplantation, 2024-08)Article de revue -
Characterization of the novel HLA-DRB1*04:04:20 allele by sequencing-based typing
(HLA. vol. 103, n° 3, 2024-03)Article de revue -
Les temps forts de la transplantation rénale en 2023
(Nephrologie & therapeutique. vol. 20, n° S1, pp. 1 – 9, 2024-03)Article de revue -
Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab
(World Allergy Organization Journal. vol. 17, n° 7, 2024-07)Article de revueLibre acceso -
Intrinsic capacity and frailty in older adults with end-stage kidney disease undergoing pre-kidney transplant comprehensive geriatric assessment
(Journal of Nutrition, Health and Aging. vol. 28, n° 6, 2024-06)Article de revueLibre acceso -
Recommandations pour l’évaluation du risque de maladie cardiovasculaire et thromboembolique veineuse avant l'instauration d'une thérapie ciblée dans les rhumatismes inflammatoires chroniques
(Revue du Rhumatisme (Edition Francaise). vol. 91, n° 2, pp. 143 – 157, 2024-03)Article de revue -
Characterization of the novel HLA-DRB3*02:194 allele by sequencing-based typing
(HLA. vol. 103, n° 1, 2024-01)Article de revue